scispace - formally typeset
J

Joseph Bondy-Denomy

Researcher at University of California, San Francisco

Publications -  94
Citations -  6442

Joseph Bondy-Denomy is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: CRISPR & Bacteriophage. The author has an hindex of 32, co-authored 73 publications receiving 4508 citations. Previous affiliations of Joseph Bondy-Denomy include University of Toronto & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system

TL;DR: The first examples of genes that mediate the inhibition of a CRISPR/Cas system are described, found in the genomes of bacteriophages infecting Pseudomonas aeruginosa and provides new insight into the co-evolution of phages and bacteria.
Journal ArticleDOI

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins

TL;DR: Four unique type II-A CRISPR-Cas9 inhibitor proteins encoded by Listeria monocytogenes prophages present tools that can be used to regulate the genome engineering activities of CRISpr-Cas 9.
Journal ArticleDOI

Multiple mechanisms for CRISPR–Cas inhibition by anti-CRISPR proteins

TL;DR: The first examples of proteins produced by phages that inhibit a CRISPR–Cas system are identified, and the diverse sequences and mechanisms of action of these anti-CRISPR proteins imply an independent evolution, and foreshadow the existence of other means by which proteins may alter CRISpr–Cas function.
Journal ArticleDOI

Disabling Cas9 by an anti-CRISPR DNA mimic

TL;DR: It is shown that the anti-CRISPR protein AcrIIA4 binds only to assembled Cas9–single-guide RNA (sgRNA) complexes and not to Cas9 protein alone, demonstrating that inhibitors can modulate the extent and outcomes of Cas9-mediated gene editing.
Journal ArticleDOI

The CRISPR/Cas Adaptive Immune System of Pseudomonas aeruginosa Mediates Resistance to Naturally Occurring and Engineered Phages

TL;DR: These phages are only the second identified group of naturally occurring phages demonstrated to be blocked for replication by a nonengineered CRISPR/Cas system, and the results provide the first evidence that the P. aeruginosa type I-F CRIS PR-Cas system can function in phage resistance.